Our findings seem to support the data obtained in a study aimed at exploring whether ubiquitin-activating enzyme E1, ubiquitin-conjugating enzyme E2, and ubiquitin or proteasome activity are affected in peripheral blood mononuclear cells (PBMC) of AD and MCI subjects compared to healthy controls. This evidence concerns the gene RPS27A and Alzheimer disease.